Tax Rule Scuppers $8 Billion Deal -- WSJ
May 24 2016 - 3:03AM
Dow Jones News
Fertilizer makers OCI, CF Industries abandon merger in wake of
Treasury restrictions
By Ian Walker and Maarten van Tartwijk
U.S. fertilizer maker CF Industries Holdings Inc. and Dutch
rival OCI NV called off their planned $8 billion merger, the latest
multibillion-dollar transaction to run afoul of changes to U.S. tax
rules designed to restrict so-called inversion deals.
The companies said they were unable to come up with a structure
for a deal to combine CF Industries with some of OCI's operations
that would create value for shareholders, citing a tougher
regulatory and commercial environment.
"There was no meeting of the minds, in terms of valuations,"
said CF Industries Chief Executive Tony Will on Monday. He said CF
Industries was eager to restart its share buyback program after a
long hiatus during the deal talks.
CF Industries will pay a $150 million breakup fee; it has $2.7
billion in cash. Shares in OCI fell more than 9% in Amsterdam after
the announcement. CF Industries' stock was up 4.4% at 4 p.m.
trading in New York on Monday.
OCI Chief Executive Nassef Sawiris said in a joint statement
that he hoped to explore "alternative ways of collaboration or
structures" with CF Industries, though Mr. Will later played down
the prospect because of valuations.
"For right now, I think we're both headed in our own direction,"
Mr. Will said on a conference call.
The decision is the latest deal to fall apart after the U.S.
Treasury last month announced further administrative action against
inversions, which had helped drive mergers-and-acquisitions
activity to record highs as U.S. companies looked to foreign deal
making to lower their tax bill.
In an inversion deal, U.S. companies moved their corporate
headquarters to a country with a more favorable tax regime,
typically through merging with a smaller firm. It enabled them to
repatriate foreign profits without paying U.S. taxes.
The crackdown on tax-fueled mergers led Pfizer Inc. and Allergan
PLC last month to abandon their planned $150 billion merger, which
would have moved the biggest drug company in the U.S. to Ireland.
The companies said their decision was driven by adverse changes in
tax law.
CF Industries of Deerfield, Ill., and OCI initially planned to
register the combined company in the U.K., lowering its overall tax
rate to 20% from 34%. They subsequently agreed in December to move
tax residency to the Netherlands, where the corporate tax rate is
25%, to satisfy tougher inversion rules put in place by the U.S.
Treasury last November.
CF Industries sought to acquire the European and North American
operations of OCI as well as its global distribution assets. OCI
was established in Egypt by the Sawiris, a prominent Egyptian
business family, but it is incorporated and listed in the
Netherlands.
A deal would have led to a global nitrogen-fertilizer giant. CF
Industries is one of the world's largest manufacturers and
distributors of nitrogen fertilizers for agricultural purposes.
OCI, which operates in Egypt, Algeria, the Netherlands and the
U.S., makes natural-gas-based fertilizers and industrial
chemicals.
The deal's collapse comes as consolidation has intensified in
the agrochemicals sector. Germany's Bayer AG has made an
unsolicited $62 billion bid for seeds supplier Monsanto Co. Swiss
pesticide and seeds company Syngenta AG agreed to a $43 billion
takeover by China National Chemical Corp., known as ChemChina,
earlier this year.
Write to Ian Walker at ian.walker@wsj.com and Maarten van
Tartwijk at maarten.vantartwijk@wsj.com
Corrections & Amplifications
CF Industries is based in Deerfield, Ill. A previous version of
this article misspelled Deerfield.
(END) Dow Jones Newswires
May 24, 2016 02:48 ET (06:48 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
OCI NV (EU:OCI)
Historical Stock Chart
From Nov 2024 to Dec 2024
OCI NV (EU:OCI)
Historical Stock Chart
From Dec 2023 to Dec 2024